Novo Holdings A/s
10% Owner | 10% Owner, See Remarks
22 companies
Insider Signal Score
58
GoodTrades Analyzed
24
12M Win Rate
60.9%
Avg 3M Return
-3.5%
Avg 12M Return
+11.1%
Novo Holdings A/s is a 10% Owner at Edgewise Therapeutics, Inc. with holdings across 22 companies. Recent SEC Form 4 filings include 6 buys and 4 sells.
Estimated insider holdings value: $2714.8M based on current market prices.
Holdings by Company
EWTXSep 14, 2022
Current Shares6.07M
Value$214.45M
Net Activity+1.11M
Bought: 1.11MSold: 0
IOBTJul 26, 2024
Current Shares4.35M
Value$209.0K
Net Activity+1.40M
Bought: 2.79MSold: 1.39M
HRMYAug 21, 2020
Current Shares4.28M
Value$132.55M
Net Activity+132.5K
Bought: 132.5KSold: 0
ACLXFeb 8, 2022
Current Shares4.02M
Value$462.22M
Net Activity+833.3K
Bought: 833.3KSold: 0
BOLTJul 13, 2022
Current Shares3.70M
Value$17.30M
Net Activity-400,000
Bought: 400.0KSold: 800.0K
OKURJun 23, 2023
Current Shares3.33M
Value$13.02M
Net Activity+566.7K
Bought: 666.7KSold: 100.0K
NKTXJul 14, 2020
Current Shares2.79M
Value$8.91M
Net Activity+555.6K
Bought: 555.6KSold: 0
MPLTOct 28, 2025
Current Shares2.73M
Value$74.90M
Net Activity+952.9K
Bought: 952.9KSold: 0
SPRBMar 21, 2024
Current Shares2.55M
Value$144.07M
Net Activity-2,189,336
Bought: 2.46MSold: 4.65M
GLTONov 2, 2020
Current Shares2.50M
Value$71.66M
Net Activity+333.3K
Bought: 333.3KSold: 0
GRTXFeb 18, 2021
Current Shares2.46M
Value$245.9K
Net Activity-450,000
Bought: 500.0KSold: 950.0K
PRAXOct 20, 2020
Current Shares2.44M
Value$805.94M
Net Activity0
Bought: 0Sold: 0
MISTNov 25, 2019
Current Shares2.43M
Value$4.67M
Net Activity+93.3K
Bought: 333.3KSold: 240.0K
ALGSOct 20, 2020
Current Shares2.41M
Value$15.55M
Net Activity+200.0K
Bought: 200.0KSold: 0
IRTCOct 25, 2016
Current Shares2.12M
Value$256.34M
Net Activity+100.0K
Bought: 100.0KSold: 0
INGNJun 2, 2021
Current Shares2.08M
Value$14.60M
Net Activity-1,470,000
Bought: 0Sold: 1.47M
ANABAug 21, 2017
Current Shares1.94M
Value$134.26M
Net Activity-1,046,900
Bought: 50.0KSold: 1.10M
MIRMJul 22, 2019
Current Shares1.87M
Value$200.40M
Net Activity+575.0K
Bought: 575.0KSold: 0
KALVOct 12, 2017
Current Shares1.73M
Value$46.14M
Net Activity-2,901,930
Bought: 0Sold: 2.90M
CRVSJul 8, 2020
Current Shares1.39M
Value$21.61M
Net Activity-1,097,882
Bought: 1.93MSold: 3.03M
IRONJun 28, 2023
Current Shares1.09M
Value$74.46M
Net Activity-1,250,000
Bought: 0Sold: 1.25M
MGXFeb 13, 2024
Current Shares939.2K
Value$1.32M
Net Activity+900.0K
Bought: 900.0KSold: 0
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Sell | 100,000 | $7.10 | $709,740.00 | -2.9% | +0.6% | -77.0% | |
| Feb 16, 2023 | SPRB Spruce Biosciences, Inc. | 10% Owner | Buy | 2,208,000 | $3.17 | $6,999,360.00 | +48.9% | -8.4% | +100.0% | |
| Sep 14, 2022 | EWTX Edgewise Therapeutics, Inc. | 10% Owner | Buy | 484,496 | $10.32 | $4,999,998.72 | +8.7% | -23.8% | -35.7% | |
| Jul 13, 2022 | BOLT Bolt Biotherapeutics, Inc. | 10% Owner | Sell | 800,000 | $2.00 | $1,600,000.00 | -17.8% | -41.9% | -43.5% | |
| Feb 8, 2022 | ACLX Arcellx, Inc. | 10% Owner | Buy | 833,333 | $15.00 | $12,499,995.00 | +26.2% | -52.0% | +75.2% | |
| Nov 9, 2021 | IOBT Io Biotech, Inc. | 10% Owner | Buy | 325,000 | $14.00 | $4,550,000.00 | +11.0% | -36.9% | -81.2% | |
| Jun 2, 2021 | INGN Inogen Inc | 10% Owner | Sell | 680,000 | $57.32 | $38,977,600.00 | -24.6% | +1.6% | -54.4% | |
| May 19, 2021 | SPRB Spruce Biosciences, Inc. | 10% Owner | Sell | 475,000 | $13.90 | $6,602,500.00 | -9.5% | -51.6% | -91.2% | |
| Apr 13, 2021 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Buy | 666,666 | $15.00 | $9,999,990.00 | +24.1% | -26.7% | -77.4% | |
| Mar 30, 2021 | EWTX Edgewise Therapeutics, Inc. | 10% Owner | Buy | 625,000 | $16.00 | $10,000,000.00 | +12.6% | -23.8% | -70.3% |